Pulike Subsidiary Obtains New Veterinary Drug Registration Certificate for Fluralaner and Moxidectin Spot-On Solution

Product / Tech
โดย CLS·CN·Read original
Summary · why it matters

Pulike's wholly owned subsidiary Luoyang Huizhong Veterinary Medicine Co., Ltd., together with other organizations, has received approval from the Ministry of Agriculture and Rural Affairs for the Fluralaner and Moxidectin Spot-On Solution as a new veterinary drug, along with a New Veterinary Drug Registration Certificate. The product is a Class II new veterinary drug used to treat flea and intestinal roundworm infections in cats, providing up to 12 weeks of protection. The company stated that obtaining this certificate reflects its emphasis on technological innovation and increased R&D investment, and will play a positive role in enhancing product competitiveness and driving growth in its pet business segment.

Impact on stocks 1

Others▲ · 1 stocks
Pulike Biological Engineering
603566
▲ PositiveTechnologyrelevance

Subsidiary obtains new veterinary drug registration certificate for Fluralaner and Moxidectin Spot-On Solution, enhancing product competitiveness and pet business growth.

Off-coverage companies 1

洛阳惠中兽药有限公司Private▲ Positive
Technologyrelevance

As the wholly owned subsidiary, Luoyang Huizhong Veterinary Medicine Co., Ltd. is directly involved in obtaining the new veterinary drug registration certificate.

© 2026 MarketDXNews